Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Mar 31, 2023
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights Mar 30, 2023
Avenue Therapeutics Reports Full Year 2022 Financial Results and Recent Corporate Highlights Mar 30, 2023
Journey Medical Corporation Reports Full-Year 2022 Financial Results and Recent Corporate Highlights Mar 29, 2023
Journey Medical Corporation to Announce Year End 2022 Financial Results on March 29, 2023 Mar 22, 2023
Journey Medical Corporation Announces Completion of Treatment Assessing Impact of DFD-29 (Minocycline Modified Release Capsules 40 mg) on Microbial Flora in a Separate Phase 1 Clinical Trial Mar 16, 2023
